Fortel My Health
Pohang · Founded 2022
About Fortel My Health
Fortel My Health provides an innovative liquid biopsy service, 'Magnolia,' designed to simultaneously screen for ovarian and endometrial cancers. The service utilizes platelet-derived RNA analysis combined with an artificial intelligence (AI) algorithm for cancer diagnosis. This advanced technology was developed to address the limitations of traditional imaging diagnostics and tissue biopsies.
Company Facts
- Founded: 2022
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: Seed
- Last round: Seed (Jul 2025)
- Website: foretell.bio
- Phone: +82 054-261-6636
Canonical: https://fsome.com/organization/fortel-my-health-8349766 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.